MET kinase-IN-2

MET kinase-IN-2 is a potent, selective, orally bioavailable MET kinase inhibitor with an IC50 of 7.4 nM. MET kinase-IN-2 has antitumor activity[1].

Product Specifications

CAS Number

[2101241-90-9]

UNSPSC

12352005

Target

C-Met/HGFR

Type

Reference compound

Related Pathways

Protein Tyrosine Kinase/RTK

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/met-kinase-in-2.html

Purity

98.39

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C1C(C2=CC=CC=C2)=CNC3=C1C(NC4=CC=C(OC5=CC=NC6=CC(OCC(C)(O)C)=CC=C56)C(F)=C4)=NC=C3

Molecular Formula

C33H27FN4O4

Molecular Weight

562.59

References & Citations

[1]Chen T, et al. Discovery of 1,6-naphthyridinone-based MET kinase inhibitor bearing quinoline moiety as promising antitumor drug candidate. Eur J Med Chem. 2020;192:112174.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, protect from light, stored under nitrogen)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

NBP2-98794AF750 0.1 mL

Rabbit Polyclonal Ets-1 Antibody [Alexa Fluor 750]

View Details

PVTB00736-2a 2 µg

pcDNA6-Flag-CBX4 Plasmid

View Details

043505-ML550 100 µL

UBAC1, CT (UBAC1, GBDR1, KPC2, UBADC1, Ubiquitin-associated domain-containing protein 1, E3 ubiquitin-protein ligase subunit KPC2, Glialblastoma cell differentiation-related protein 1, Kip1 ubiquitination-promoting complex protein 2) (MaxLight 550) discontinued

View Details

MBS1462775-01 0.02 mg (E-Coli)

Recombinant Aedes aegypti Enhancer of yellow 2 transcription factor (e (y)2)

View Details

MBS1462775-02 0.1 mg (E-Coli)

Recombinant Aedes aegypti Enhancer of yellow 2 transcription factor (e (y)2)

View Details

MBS1462775-03 0.02 mg (Yeast)

Recombinant Aedes aegypti Enhancer of yellow 2 transcription factor (e (y)2)

View Details